L-selectin in Tuberculosis-HIV Coinfection: Linking Immune Activation to Disease Outcome
2024 | Elite Journal of Health Sciences | Pp. 41-58
Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) coinfection present a significant challenge to global health, with complex interactions between these pathogens influencing disease outcomes and treatment responses. L-selectin, a key mediator of leukoc...